ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2017

Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease.

Veronick Benoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.